![Thibaut Roulon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thibaut Roulon
Directeur/Membre du Conseil chez
NH THERAGUIX SAS
Profil
Thibaut Roulon is currently Director at Depixus SAS, Nouscom AG, LimFlow SA, AlgoTherapeutix SAS, Imcheck Therapeutics SAS (since 2019), NH TherAguix SAS (since 2019), and Investment Director at BPIFrance Investissement SAS (since 2010).
Also holds positions as Member-Supervisory Board at ADEMTECH SA and Step Pharma SAS. Former roles include Director at Poxel SA, Sangamo Therapeutics France SAS, Sensorion SA, Biom'Up SA, Gensight Biologics SA, GamaMabs Pharma SA, CorWave SA; Independent Director at Advicenne SA from 2011 to 2026; and Chargé d'Affaires at Bioam Gestion SA from 2005 to 2010.
Education includes undergraduate degree from École Centrale Paris and doctorate from Université Pierre et Marie Curie.
Postes actifs de Thibaut Roulon
| Sociétés | Poste | Début |
|---|---|---|
| NH THERAGUIX SAS | Directeur/Membre du Conseil | 22/02/2019 |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Directeur/Membre du Conseil | - |
ADEMTECH SA
 ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services Specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications | Directeur/Membre du Conseil | - |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology Develops medical devices for the treatment of CLTI | Directeur/Membre du Conseil | - |
Algotherapeutix SAS
 Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Directeur/Membre du Conseil | - |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Directeur/Membre du Conseil | 04/12/2019 |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Directeur/Membre du Conseil | - |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national. | Analyste en capital-investissement | 14/10/2010 |
Depixus SAS
 Depixus SAS Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops a technology for genetic and epigenetic analysis | Directeur/Membre du Conseil | - |
Anciens postes connus de Thibaut Roulon
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Thibaut Roulon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Bioam Gestion SA
 Bioam Gestion SA Investment ManagersFinance BG is a venture capital investment management firm specialized in early-stage financing of biotechnology companies. They target start-ups with high growth potential, spawned by French and European public or private sector life science research, and more particularly applications in the healthcare, environment, agricultural and food industries. Within the healthcare sector BG focuses on biopharmaceuticals, medical instrumentation and diagnosis systems. BG provides seed capital, generally investing in the first institutional round of financing, and later participating in subsequent rounds. The firm usually joins forces with French or foreign co-investors. BG invests in France and in Europe. The firm sources deals through their extensive network in the French academic community and in the biopharmaceutical industry. BG is an active investor who sits on the board and provides strategic advisory as well as development assistance to their portfolio companies. | Finance |
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services Specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications | Commercial Services |
École Centrale Paris
 École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national. | Finance |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Biom'Up SA
 Biom'Up SA Medical SpecialtiesHealth Technology Manufactures medical devices based on collagen technology | Health Technology |
Advicenne SA
 Advicenne SA Pharmaceuticals: GenericHealth Technology Develops and markets pediatric drugs | Health Technology |
Gensight Biologics SA
 Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services Specializes in developing monoclonal antibodies | Health Services |
CorWave SA
 CorWave SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures blood pumps | Commercial Services |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
LimFlow SA
LimFlow SA Medical SpecialtiesHealth Technology Develops medical devices for the treatment of CLTI | Health Technology |
Depixus SAS
Depixus SAS Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops a technology for genetic and epigenetic analysis | Commercial Services |
NH TherAguix SAS
 NH TherAguix SAS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops nanomedicine for cancer, combining imaging and radiotherapy | Health Technology |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Health Technology |
